about
Primary osteosarcoma of the breast: A case report.VEGF-C expression is not a prognostic factor in locally advanced colon adenocarcinoma.Medium-chain triglycerides/long-chain triglycerides versus long-chain triglycerides in treatment of cancer patients with major body mass loss. Survival in patients with refractory cachexia.Evaluation of 12-lipoxygenase (12-LOX) and plasminogen activator inhibitor 1 (PAI-1) as prognostic markers in prostate cancer.Protective stomy as a complement to anterior rectal resection. Analysis of authors' material and literature review.VEGF, Flt-1, and microvessel density in primary tumors as predictive factors of colorectal cancer prognosisSame Quality of Life for Polish Breast Cancer Patients Treated with Mastectomy and Breast Reconstruction or Breast-Conserving Therapy.Independent psychometric validation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24).The concentration of 12-lipoxygenase in platelet rich plasma as an indication of cancer of the prostateAnalysis of postoperative morbidity and mortality following surgery for gastric cancer. Surgeon volume as the most significant prognostic factor.VEGF-C and VEGF-D overexpression is more common in left-sided and well-differentiated colon adenocarcinoma.The HER2 gene and HER2 protein status and chromosome 17 polysomy in gastric cancer cells in own material.The relationship between HER2 overexpression and angiogenesis in gastric cancerExtremely High Mortality Rate after a Successful Gastrectomy for Cancer in Older Adults.[Surgical treatment of megacolon--case report]L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolic disorders in cancer cachexiaL-carnitine and cancer cachexia. II. Effects of lipid emulsion used in total parenteral nutrition on parameters of hemostasis and inflammatory state in L-carnitine deficiency in myocytesIs age a risk factor of postoperative complications in colorectal cancer?The value of intraoperative liver ultrasound assessment using an intraabdominal probe during laparotomy performed for oncological reasonsUltrasound and Clinical Preoperative Characteristics for Discrimination Between Ovarian Metastatic Colorectal Cancer and Primary Ovarian Cancer: A Case-Control Study
P50
Q33727760-A77E23C9-F914-49BC-AE9E-36767F4223DFQ36516066-62B05B49-7A7B-45FA-8329-C82FCB3121FBQ37306560-7A43EE7E-A122-48E0-94B6-426C2B6BE0D5Q37695659-D450C788-AAD3-4092-BA51-E13F52FAB24DQ37967999-B567E6D0-8505-4ADA-BB69-975C072BB85FQ38375308-2D45FA62-F0FD-4EB6-BFA8-B5FB691C93C0Q38798812-D77C7D1B-1D18-40C5-BAB6-5F1A6BC5C08AQ39036842-1B0FEFE9-6CB7-4D83-9129-7E48E087D497Q41898117-B22489FD-09F9-496F-9008-086CE5B543E2Q43274315-FD78967B-FA6C-47D5-A97D-3845BE5CFBB1Q46095352-BBBDAA94-48DF-4D39-B2E8-2C185E0CF957Q50460699-FE60A7EA-B5C5-4CFC-ABC8-F2D7ED1BFA57Q58598190-5A94BBE0-9962-4440-A8E2-8350B40730D4Q64921937-92577DF4-0AA8-4CE9-A560-E428CDE5A822Q83180030-4FB84DAD-4542-4530-8E07-F1B2424CCA53Q84075143-F8200AF3-4759-4E5A-8878-780591E969E5Q84075169-2A93D9EF-4A0F-4BA7-B569-6DCEAB494EBDQ86543616-5BD32061-08FB-402D-ABC4-B85329415DC4Q86592831-793AEDDC-7B7A-469D-98B8-7BAA762C3817Q91726719-8CC853A8-6ACF-4378-9ABC-216DB131DF10
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mariusz Szajewski
@ast
Mariusz Szajewski
@en
Mariusz Szajewski
@es
Mariusz Szajewski
@nl
Mariusz Szajewski
@pl
type
label
Mariusz Szajewski
@ast
Mariusz Szajewski
@en
Mariusz Szajewski
@es
Mariusz Szajewski
@nl
Mariusz Szajewski
@pl
altLabel
Mariusz Mirosław Szajewski
@pl
prefLabel
Mariusz Szajewski
@ast
Mariusz Szajewski
@en
Mariusz Szajewski
@es
Mariusz Szajewski
@nl
Mariusz Szajewski
@pl
P214
P106
P1153
26323826100
P214
P31
P3124
P496
0000-0002-7595-7152
P7859
viaf-315220868